0930 Carmot EMBARGO 7AM ET WEDS
BioCentury & Getty Images

Product Development

Partner Amgen becomes investor as Carmot pushes diabetes therapies ahead with $47M series C 

Carmot advances diabetes candidates discovered using its validated platform with series C round

Sep 30, 2020 | 7:01 PM GMT

Amgen has joined the syndicate of investors backing Carmot in a $47 million

Read the full 555 word article

How to gain access

Continue reading with a
two-week free trial.